This report will:  

  • Provide an overview of the monoclonal antibody (mAbs) industry: market value, key on the future of antibody-based drug players, opportunities and the future 
  • Explore what’s next for antibody-based drugs and where the opportunity is coming from 
  • Include an interview Bio-Rad’s John Cardone, who shares expertise on the future of antibody-based drug discovery  
  • Share significant future trends for the therapeutic antibody market